Assistant Professor

The petition was approved based on 12 peer-reviewed publications with over 468 citations, including a paper in the top 10% of its field. The petitioner demonstrated extraordinary ability through his service as a reviewer for 14 journals and his role on multiple international editorial boards. His research into type 2 diabetes treatments and Zika virus virulence provided evidence of original contributions of major significance.

The case was approved based on the petitioner's 15 peer-reviewed scientific articles with a cumulative impact factor of 69.504 and 233 citations from peers in 37 countries. He demonstrated extraordinary ability through 92 peer review assignments and editorial positions at 5 prestigious journals. His research provided practical applications for treating complex diseases like diabetes and tuberculosis.

The petition was approved based on 22 peer-reviewed journal articles (9 as first or co-first author) and 252 citations from researchers in 30 countries. Additionally, the petitioner completed 28 peer reviews for acclaimed journals and received funding from prestigious organizations like the NIH and AHA.

The petition was approved based on 25 peer-reviewed publications and one book chapter in high-impact journals like NEJM and JAMA, which garnered over 2,800 citations from 70 countries. The petitioner satisfied three EB-1A criteria: original scientific contributions, scholarly authorship, and judging the work of others. Additionally, the work was supported by funding from prominent agencies such as the NIH and NCI.